Genacol’s AminoLock® Collagen is produced using a unique manufacturing procedure that takes collagen, and breaks it down to peptides that have a very low molecular weight.
The result: a unique Collagen Hydrolysate of less than 1,000 Dalton that allows for greater absorption by the human body.
Recently, ConsumerLab.com, an independent organization that evaluates nutritional products in the USA, recognized Genacol’s clinical study as: ONE OF THE LARGEST STUDIES ABOUT COLLAGEN HYDROLYSATE. The report also mentions that after 6 months of taking the collagen (Genacol) 51.6% of the participants reported better joint health (Bruyere, Comp Ther Med 2012).
Genacol’s AminoLock® Collagen is a unique protein complex that creates the lowest molecular size peptides in the world, creating the benefit of superior bioavailability and proven effectiveness for joint health (supported by 2 published scientific studies).
The proof of the effectiveness in using Genacol’s unique very low molecular weight AminoLock® Collagen is now patent pending in the USA (Application number 62/426,908) and Canada (Application number 017808-0005).